New pill shows promise against advanced cancers in early trial
Disease control
Not yet recruiting
This early-stage study tests a new tablet called ZL-85FA in 51 adults with advanced breast, ovarian, fallopian tube, primary peritoneal, or prostate cancer. The main goal is to check safety and how well the drug works at shrinking tumors. Participants must be 18-75 years old and …
Phase: PHASE1, PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC